Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 38, 2024 - Issue 7
121
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Rinderidine and oblongifolidine new pyrrolizidine alkaloids from Rindera oblongifolia M. Popov and their absolute configurations

, ORCID Icon, , ORCID Icon, , & ORCID Icon show all
Pages 1157-1167 | Received 03 Oct 2021, Accepted 04 Oct 2022, Published online: 18 Oct 2022
 

Abstract

The alkaloid composition of Rindera oblongifolia was studied, in which the pyrrolizidine alkaloids echinatine and trachelanthamine N-oxide, as well as two new quaternary salts namely rinderidine and the oblongifolidine were isolated. The structures of the isolated new alkaloids were elucidated by NMR spectroscopy. The absolute configuration of lindelofine, trachelanthamine N-oxide, rinderidine and oblongifolidine was established by single crystal X-ray diffraction as: 1 R, 4 R, 8 R, 2′S, 3′R; 1 R, 4S, 8S, 2′S, 3′R; 4 R, 7S, 8 R, 2′S, 3′S; 4 R, 7S, 8 R, 2′S, 3′S (7′′S, 8′′R) respectively. Both new pyrrolizidine alkaloids showed no cytotoxicity against four cancer cell lines such as HeLa, НEр-2, HBL-100 and CCRF-CEM.

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by the Program for Fundamental Scientific Research of the Uzbekistan Academy of Sciences.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.